Skip to content

Author

Michelle Vanecek

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Real-world screening for metabolic dysfunction-associated steatotic liver disease among adults with type 2 diabetes.

The impact of population-level MASLD screening is limited by implementation barriers and future efforts should focus on direct-to-patient outreach and methods to identify patients without competing risks who are most likely to benefit from MASLD diagnosis and specific treatment.

Michael L. Volk, Annabel Simons, Michelle Vanecek et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.